comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 04:11:20 - browse：4686

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But researchers have found that many clinical trials exclude the people of color who are often most affected by the diseases that drugs treat.

To help fix that problem, Congress passed a law requiring companies to give the FDA their plans for diversifying clinical trials. As part of that process, the agency was expected to issue guidance by the end of last year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Study: Pain burden is higher in Black NFL players than white ones

focus

WSS

Palantir health business leans on meeting customers’ needs

California’s proposed $25 per hour health care minimum wage

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Charles Manson follower Leslie Van Houten released from prison after 53 years

New research casts further doubt on a common procedure used with IVF

VC firm General Catalyst wants to buy a health system

entertainment

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

Affirmative action in medical school literally saved lives

Analysis of telehealth claims data suggest service duplication

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Jerome Adams on the need for new antivirals for Covid

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Guidelines to prevent youth baseball injuries need more muscle

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

At least 13 dead in Texas as scorching temps continue

Why 40% Americans with Parkinson’s don’t see a neurologist

focus

Palantir health business leans on meeting customers’ needs

California’s proposed $25 per hour health care minimum wage

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

A virus, fished out of a lake, may have saved a man’s life

How the political right came to back psychedelics to treat trauma

3 questions for the future of Biden's cancer moonshot

entertainment

focus

hotspot

focus